StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Ajit Mishra, Religare

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byAjit Mishra, ReligareHorizon: Swing (≤2wk)11 Nov 2026via NDTV Profit (Live)

Entry₹1,399Inferred
Target₹1,460
Total upside +4.36%
Stop loss₹1,345-3.86% risk
CMP₹1,3801d ago
Active-1.36%+5.80%upside left 10d left
Follow Ajit Mishra for new calls(26% target hit, 122 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:36 am IST
7 supporting1 opposing
Supports the BUY call (7)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Dr Reddy's Laboratories gets Brazil regulator approval for generic semaglutide

NewsCnbc-Tv18·5 Nov · 1w ago

(opens in new tab)

Dr. Reddy's Laboratories has received marketing authorization for its generic semaglutide injection in Brazil.

NSE · Press Release·5 Nov · 1w ago

(opens in new tab)

Dr. Reddy's Laboratories has received marketing authorization from Brazil's ANVISA for its generic semaglutide injection, used for treating type 2 diabetes.

BSE · Company Update·5 Nov · 1w ago

(opens in new tab)

The company received US regulatory approval for a generic HIV prevention injection for distribution in developing countries.

BSE · Company Update·3 Nov · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

RSI at 74 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Ajit Mishra, Religare

Every call and its outcome